About Us

Barker-Alfanxo Pharmaceutical Industry

Barker-Alfanxo Pharmaceutical Industrial Ltd is among the leading third-party pharma manufacturers that aim to improve the health of the Nigerian population with its extensive and exclusive product range. Our company supplies human and veterinary range injections throughout Nigeria. Since its inception in 1994, Barker-Alfanxo Pharmaceutical has been involved in the healthcare sector, developing a growing portfolio of best-in-class pharmaceutical injectables formulations.

Our company is a large and dynamic group that has established a leading position in the field of pharmaceutical formulations. We have earned a reputation for excellence and superiority based on consistently offering high-quality products, an expanding product portfolio, on-time deliveries, and state-of-the-art manufacturing facilities. Our production area is equipped with modern technology and high-tech machinery that allow us to manufacture a vast range of drugs in the shortest possible time. Barker-Alfanxo Pharmaceutical follows the guidelines laid down by the WHO and NAFDAC and utilizes GMP-certified units to offer exclusively manufacturing deals for all types of human and veterinary injections, including Vitamin B Complex, Stremtomycine, Chloroquine, Fortified Procaine, Penicillin Injection, etc.

Barker-Alfanxo Pharmaceutical Industrial Ltd was conceived in 1992 and started in 1994 in our temporary site with only two products: Vitamin B-Complex injection (10ml vials) and 30ml Chloroquine Phosphate injection. Other products like Fortified Procaine, penicillin injection, Streptomycin injection, and Chloramphenicol Sodium Phosphate were added in 2004. Hydrocortisone sodium phosphate 100mg injection was added by 2006 July.

Our In-House Quality Control Laboratories and manufacturing plants test all of our products. We manufacture all kinds of pharmaceutical injectables at the best industry prices to ensure they are affordable for every individual. Our company has strong ties with the best networking teams that help us to deliver all orders to our customers promptly and as per their commitments. As a customer-oriented company, we do not compromise on quality, which has enabled us to establish a niche position in the industry.

Innovation & Prudence

Creativity, innovation and prudence made our drugs relevant in Nigeria and exported to West African Country with inroad into South Africa.

Our Vision

At our pharmaceutical company, our vision is to be a leader in the development and manufacturing of innovative and effective medicines that improve the health and well-being of people worldwide. We are committed to investing in research and development to create breakthrough therapies that address unmet medical needs and improve patients’ lives. We strive to achieve this vision by maintaining the highest standards of quality, safety, and ethics in all our operations and fostering a culture of collaboration, creativity, and continuous improvement. Our ultimate goal is to be a trusted partner for healthcare providers, patients, and communities worldwide, delivering sustainable value and making a meaningful difference in people’s lives.

Our Mission

Our pharmaceutical company is dedicated to improving global health by developing and manufacturing safe, effective, and innovative pharmaceutical products. Our mission is to prioritize patient needs and provide healthcare professionals with high-quality treatments that meet the highest standards of safety and efficacy. We are committed to ethical business practices and strive to earn the trust of our stakeholders by maintaining transparency, integrity, and social responsibility in all our operations. We invest heavily in research and development to discover and bring to market new therapies that address unmet medical needs and improve patient outcomes. Our goal is to create sustainable value for our shareholders, employees, and communities while contributing to the advancement of public health worldwide.

Certified & Registered

Latest News & Updates

By
Barker-Alfanxo
Apr 29 2023

Exploring the ethics of drug pricing and access to medicines

Access to affordable medicines is a fundamental aspect of modern healthcare, and ethical considerations play a critical role in shaping the pricing...
By
Artificial intelligence (AI) has the potential to revolutionize the pharmaceutical industry by accelerating drug discovery and development. AI can be used to analyze vast amounts of data and identify patterns that would be difficult or impossible for humans to detect. This has significant implications for the development of new drugs and the improvement of existing treatments. What is drug discovery and development? Drug discovery and development is the process of identifying and developing new drugs. The process involves several stages, including target identification, lead generation, lead optimization, preclinical testing, clinical trials, and regulatory approval. How is AI being used in drug discovery and development? AI is being used in several ways in drug discovery and development, including: Target identification: AI can be used to analyze large amounts of data to identify potential drug targets, including proteins and genes that play a role in disease development. Lead generation: AI can be used to generate new drug candidates by predicting how molecules will interact with a particular target. Lead optimization: AI can be used to optimize drug candidates by predicting which modifications will improve the drug's efficacy and reduce side effects. Predicting drug efficacy and toxicity: AI can be used to predict how a drug will perform in clinical trials, including efficacy and toxicity, which can reduce the cost and time associated with clinical trials. Drug repurposing: AI can be used to identify new uses for existing drugs, which can reduce the time and cost associated with developing new drugs. What are the benefits of using AI in drug discovery and development? Using AI in drug discovery and development has several benefits, including: Increased efficiency: AI can analyze vast amounts of data in a fraction of the time it would take humans to do the same analysis, reducing the time and cost associated with drug development. Improved success rates: AI can identify patterns and predict outcomes that would be difficult or impossible for humans to detect, increasing the success rates of drug development. Reduced costs: AI can reduce the costs associated with drug development by predicting which drug candidates are most likely to succeed, reducing the need for expensive clinical trials. Improved patient outcomes: AI can identify new drug targets and drug candidates that have the potential to improve patient outcomes and reduce side effects. Drug repurposing: AI can identify new uses for existing drugs, which can reduce the time and cost associated with developing new drugs. Conclusion: AI has the potential to revolutionize the pharmaceutical industry by accelerating drug discovery and development. By analyzing vast amounts of data and identifying patterns that would be difficult or impossible for humans to detect, AI can improve the efficiency, success rates, and cost-effectiveness of drug development. As AI continues to develop, we can expect to see more personalized treatments, improved patient outcomes, and a faster and more efficient drug development process.
Apr 28 2023

The role of AI in drug discovery and development

Artificial intelligence (AI) has the potential to revolutionize the pharmaceutical industry by accelerating drug discovery and development. AI can...
By
Over the past few years, there has been a growing interest in personalized medicine, a medical approach that tailors treatment to an individual's unique genetic, environmental, and lifestyle factors. Personalized medicine promises to revolutionize the way we treat and prevent diseases, and it has significant implications for the future of the pharmaceutical industry. What is personalized medicine? Personalized medicine, also known as precision medicine, is an approach to healthcare that takes into account an individual's genetic makeup, environment, and lifestyle when diagnosing and treating diseases. Personalized medicine allows physicians to customize treatments for each patient, increasing the likelihood of success and reducing adverse reactions. How is personalized medicine being used today? Personalized medicine is already being used in the treatment of several diseases, including cancer, cystic fibrosis, and cardiovascular disease. For example, cancer treatment can be personalized by analyzing the genetic mutations in a patient's tumor and identifying the most effective drugs based on the specific mutations present. What are the implications of personalized medicine for the pharmaceutical industry? The rise of personalized medicine has significant implications for the pharmaceutical industry. Here are some of the key ways that personalized medicine is expected to impact the industry: Smaller, more targeted drug development: Personalized medicine will require pharmaceutical companies to develop drugs that target specific genetic mutations or other biomarkers, resulting in smaller and more targeted drug development. Increased focus on diagnostics: Personalized medicine relies on accurate and effective diagnostic tools, which will require investment in diagnostic research and development. Data analytics: Personalized medicine generates vast amounts of data, including genetic data, clinical data, and lifestyle data. This data can be used to develop new drugs, optimize treatments, and improve patient outcomes. Improved patient outcomes: Personalized medicine has the potential to improve patient outcomes by tailoring treatments to individual patients, reducing adverse reactions, and increasing the effectiveness of treatments. Changes to regulatory framework: Personalized medicine will require changes to the regulatory framework to accommodate new diagnostic tools and personalized treatments. Conclusion: Personalized medicine is rapidly changing the healthcare landscape, with significant implications for the pharmaceutical industry. While there are challenges to implementing personalized medicine, including data privacy and ethical concerns, the potential benefits of personalized medicine are clear. As the industry adapts to the rise of personalized medicine, we can expect to see more targeted drug development, increased investment in diagnostics, and improved patient outcomes.
Apr 28 2023

The rise of personalized medicine: what it means for the future of pharma

Over the past few years, there has been a growing interest in personalized medicine, a medical approach that tailors treatment to an individual's...
By
The impact of COVID-19 on the pharmaceutical industry: challenges and opportunities
Apr 28 2023

The impact of COVID-19 on the pharmaceutical industry: challenges and opportunities

The COVID-19 pandemic has affected every aspect of our lives, including the pharmaceutical industry. The industry, which is responsible for...
× How can I help you?